Department of Pediatrics, Metabolism and Nutrition Unit, Faculty of Medicine, Hacettepe University, 06100, Ankara, Turkey.
J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S345-8. doi: 10.1007/s10545-009-9010-0. Epub 2009 Dec 23.
The peroxisomal biogenesis disorders (PBDs) comprise the Zellweger spectrum disorders (i.e., Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease) and rhizomelic chondrodysplasia punctata. Peroxisomal biogenesis disorders can be caused by mutations in any of 13 currently known PEX genes, which encode peroxins involved in peroxisomal protein import and/or assembly of the organelle. We report here on a Turkish patient who presented with unusual clinical findings, that included non-immune hydrops, dermal erythropoiesis and hypoplastic toenails, as well as common dysmorphic features of Zellweger syndrome. The patient has also pulmonary hypoplasia, which has been reported in only a few patients with Zellweger syndrome. A peroxisomal biogenesis disorder was confirmed by enzyme analysis and abnormal very long-chain fatty acid (VLCFA) profiles in plasma and fibroblast and immunofluorescence microscopy studies. Subsequent molecular genetic analysis revealed a homozygous c.856C>T mutation (R268X) in the PEX3 gene, which made this patient the third to have a defect in this gene. In contrast to those of the two previously reported patients, the cells of this patient still contained peroxisomal membrane structures (ghosts), seen by immunofluorescence microscopy analysis. The case presented here and the two previously reported cases point out that a PEX3 gene defect may present with fairly heterogeneous clinical findings. This case also raises a possibility that hydrops fetalis may be associated with a PEX3 gene defect and that peroxisomal disorders can be considered in the etiology of hydrops fetalis as well as other cell organelle disorders when one is considering yet undiscovered complementation groups in peroxisomal disorders.
过氧化物酶体生物发生障碍(PBD)包括 Zellweger 谱障碍(即 Zellweger 综合征、新生儿肾上腺脑白质营养不良和婴儿 Refsum 病)和 Rhizomelic 软骨发育不良点状。过氧化物酶体生物发生障碍可由 13 个目前已知的 PEX 基因中的任何一个突变引起,这些基因编码参与过氧化物酶体蛋白输入和/或细胞器组装的过氧化物酶。我们在此报告了一名土耳其患者,他表现出不寻常的临床发现,包括非免疫性水肿、皮肤红细胞生成和发育不良的脚趾甲,以及 Zellweger 综合征的常见畸形特征。该患者还患有肺发育不全,这仅在少数 Zellweger 综合征患者中报道过。过氧化物酶体生物发生障碍通过酶分析和血浆、成纤维细胞中异常的超长链脂肪酸(VLCFA)谱以及免疫荧光显微镜研究得到证实。随后的分子遗传学分析显示 PEX3 基因中的纯合 c.856C>T 突变(R268X),这使该患者成为第三个具有该基因缺陷的患者。与前两个报道的患者不同,该患者的细胞仍然含有过氧化物酶体膜结构(鬼影),通过免疫荧光显微镜分析可见。本病例和前两个报道的病例表明,PEX3 基因突变可能表现出相当异质的临床发现。该病例还提出了一种可能性,即胎儿水肿可能与 PEX3 基因突变有关,并且当考虑过氧化物酶体疾病中尚未发现的互补群时,过氧化物酶体疾病以及其他细胞细胞器疾病也可以被认为是胎儿水肿的病因。